Merck presented Professor David Alsteens (33), Catholic University of Louvain (UCLovain), Louvain-la-Neuve, Belgium with the 2019 Heinrich Emanuel Merck Award for Analytical Science. The award ceremony took place during the analytical conference Euroanalysis at Istanbul University in Turkey ... more
Merck and Rigaku Form Partnership to Develop Novel Molecular Structure Analysis Technology
Merck and Rigaku Corp., Tokyo, Japan, have signed a joint development agreement to develop lab consumables based on crystalline sponge technology, which determines the absolute chemical structure of organic molecules and enables X-ray crystallography without crystallization of the analyte.
“We have licensed a new technology with the potential to help labs determine absolute chemical structure quickly, even for samples on a sub-microgram scale. Our innovation project is working on dedicated consumables that will simplify the technology to enable our customers to apply it,” said Isabel De Paoli, Chief Strategy Officer at Merck. “With Rigaku, we have found an extremely competent partner to develop the best devices for the technology, and we are looking forward to working together on this project.”
Yoshiaki Watanabe, Senior Executive Vice President of Rigaku, said “Rigaku has been at the leading edge of technology in the high-end crystallography market for decades. This project will open new doors for scientists at all levels of expertise across a range of disciplines – in medicine, life science and the evolution of advanced materials.”
The approach of crystalline sponge technology can be applied to extremely small amounts of a substance, volatiles and other non-crystallizable compounds. The project simplifies the complex technology and makes it available to chemical and life science laboratories working with pharmaceuticals, fine chemicals or natural compounds that need to determine the molecular structure of substances.
The inventor of the technology, Dr Makoto Fujita, Distinguished Professor of the University of Tokyo and the Institute for Molecular Science, continues to be involved in the project through the University of Tokyo and the Japan Science and Technology Agency.
The innovation project is being hosted at the Merck Innovation Center, which aims to grow ideas into viable new businesses beyond the current scope of the company’s activities. In accordance with a company builder approach, it provides dedicated support, clear governance and decision making in a protected start-up-like environment to efficiently grow and scale innovation projects. By offering such a protected innovation ecosystem, the Innovation Center builds the bridge between the agility of a start-up and the more complex processes of an established corporate group.
Merck has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving. Financial details were not disclosed. “BSSN Software and the capabilities that it bri ... more
Merck generated very strong organic sales growth in the third quarter of 2018. However, this was impacted by negative exchange rate effects. Despite organic growth, EBITDA pre of the Group also declined in comparison with the year-earlier quarter owing to strong negative foreign exchange ef ... more
See how premium quality, unique packaging, and new 2D data matrix labels make EMSURE® inorganics and solvents the smartest choice for precise analysis. more
Buffers are an essential part of laboratory experiments. The pHast Pack™ ready-to-use buffers are specially designed to simplify your work. Simply mix the precisely pre-weighed packets with distilled water for quick results that are reliably reproducible again and again. By saving time, eff ... more
- 1Virtual screening for active substances against the coronavirus
- 2analytica 2020 is postponed
- 3Thermo Fisher Scientific to Acquire QIAGEN
- 4Smartphone lab finds coronavirus in saliva
- 5The digital laboratory live and tangible
- 6analytica 2020: Bioanalysis for personalized medicine
- 7Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization
- 8Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
- 9New membrane separates small organic molecules
- 10Innovative ways to battle Parkinson’s disease
- Merck and Rigaku Form Partnership to Develop Novel Molecular Structure Analy ...
- DKSH and Bruker AXS strengthen partnership in China
- Are Drones Coming to Life Science Labs?
- Andrew Alliance and Sartorius collaborate to provide software-connected pipettes
- SOPAT GmbH and Malvern Panalytical announce a distribution agreement for US ...